Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00724555 · ClinicalTrials.gov registry record
Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities
A clinical trial of Stroke, sponsored by Georgetown University.
- Completed
- Registry status
- 2,005
- Enrollment target
- 8
- Study locations
NCT00724555: Completed study of Stroke, sponsored by Georgetown University.
NCT00724555 is a study of Stroke that has completed, run by Georgetown University. The registered enrollment target is 2,005 participants, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (83% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00724555, a study of Stroke, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 2,005 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.
Conditions Studied
Study Locations (8)
District of Columbia
- Georgetown University, ASPIRE Coordinating Center - Washington D.C.
- Washington Hospital Center - Washington D.C.
- Sibley Memorial Hospital - Washington D.C.
- Providence Hospital - Washington D.C.
- United Medical Center (formerly known as Greater Southeast Community Hospital) - Washington D.C.
- George Washington University Hospital - Washington D.C.
- Howard University Hospital - Washington D.C.
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,005 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-01 |
What the finished NCT00724555 record still lists
NCT00724555 is an observational study that tracks outcomes without assigning an intervention. Its 2,005 participants enrollment target places it among the larger protocols in the corpus, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT00724555 lists 8 locations in 2 states (District of Columbia, New York).
Frequently Asked Questions
What is clinical trial NCT00724555 about?
NCT00724555 is a clinical study titled "Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities". The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.
What is the current status of trial NCT00724555?
This trial is currently completed. The enrollment target is 2,005 participants. The study started on 2008-02. Estimated completion is 2013-01.
What conditions does trial NCT00724555 study?
This clinical trial studies the following conditions: Stroke.
Who is sponsoring clinical trial NCT00724555?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00724555 being conducted?
This trial has 8 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00724555's enrollment target sits among peer trials
2,005 26th of 454 higher than 429 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia